In last trading session, CervoMed Inc (NASDAQ:CRVO) saw 156.41 million shares changing hands with its beta currently measuring 1.73. Company’s recent per share price level of $6.17 trading at $3.81 or 161.44% at ring of the bell on the day assigns it a market valuation of $50.93M. That closing price of CRVO’s stock is at a discount of -327.55% from its 52-week high price of $26.38 and is indicating a premium of 70.83% from its 52-week low price of $1.80. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 15.98 million shares which gives us an average trading volume of 240.89K if we extend that period to 3-months.
For CervoMed Inc (CRVO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.57. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.63 in the current quarter.
CervoMed Inc (NASDAQ:CRVO) trade information
Upright in the green during last session for gaining 161.44%, in the last five days CRVO remained trading in the green while hitting it’s week-highest on Wednesday, 03/12/25 when the stock touched $6.17 price level, adding 9.8% to its value on the day. CervoMed Inc’s shares saw a change of 163.68% in year-to-date performance and have moved 185.65% in past 5-day. CervoMed Inc (NASDAQ:CRVO) showed a performance of 181.74% in past 30-days. Number of shares sold short was 0.9 million shares which calculate 10.62 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 16.32 to the stock, which implies a rise of 62.19% to its current value. Analysts have been projecting 16.32 as a low price target for the stock while placing it at a high target of 16.32. It follows that stock’s current price would drop -164.51% in reaching the projected high whereas dropping to the targeted low would mean a loss of -164.51% for stock’s current value.
CervoMed Inc (CRVO) estimates and forecasts
This year revenue growth is estimated to rise 30.68% from the last financial year’s standing.
7 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 1.75M for the same. And 4 analysts are in estimates of company making revenue of 1.51M in the next quarter. Company posted 2.49M and 2.35M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 73.43% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -125.96% while estimates for its earnings growth in next 5 years are of -12.42%.
CervoMed Inc (NASDAQ:CRVO)’s Major holders
Insiders are in possession of 35.20% of company’s total shares while institution are holding 18.15 percent of that, with stock having share float percentage of 28.01%. Investors also watch the number of corporate investors in a company very closely, which is 18.15% institutions for CervoMed Inc that are currently holding shares of the company.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 255.64 shares of worth $1.58 million or 3.10% of the total outstanding shares. The later fund manager was in possession of 134.39 shares on Dec 31, 2024 , making its stake of worth around $0.83 million in the company or a holder of 1.63% of company’s stock.
